NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Medical Letter on the CDC & FDA


Susan Hasty, Publisher
Table of Contents . . . August 9th, 2009
Non-Subscriber - Summaries Only
Related Areas: Other Issues in Medical Letter on the CDC & FDA | Other Publications

Johns Hopkins Medical Institutions - Hepatitis C infection: treatment options equally effective, likelihood of success known early on

University of Rochester Medical Center - Breast cancer drug shows promise against serious infections

Celgene Corporation - Celgene Reports Record Second Quarter 2009 Operating and Financial Results

Chronic Obstructive Pulmonary Disease - Nycomed Announces FDA Filing for Daxas(R) in COPD

Depression - New findings reported from University of Sussex describe advances in depression

Food and Drug Law Institute - FDLI Publishes New FDA Directory With Obama Appointees

Heart Failure - Investigators at Hartford Hospital release new data on heart failure

Mental Health - Study Published in Child and Adolescent Psychiatry and Mental Health Demonstrated Once-Daily Vyvanse(R) (lisdexamfetamine dimesylate) CII Provided Significant Improvement of ADHD Symptoms for Children at

Spectrum Pharmaceuticals - FDA Designates Fast Track Status for Apaziquone EOquin® for Bladder Cancer

Tissue Engineering - Cardica Announces Publication of Pivotal PAS-Port(R) Proximal Anastomosis System Clinical Trial Results

Adverse Drug Reactions - Studies from J.C. Dowdy et al add new findings in the area of adverse drug reactions

Dermatology - Scientists at University of Sao Paulo, Department of Dermatology report research in dermatology

Phaeochromocytoma - New findings from National Institutes of Health in the area of phaeochromocytoma described

Antenatal Care - Studies from T. Kringeland and colleagues yield new information about antenatal care

Campylobacter - Studies from I.C. Schoenhofen et al have provided new data on campylobacter

Cardiology - New cardiology findings from W. Schillinger and co-authors described

Cervical Cancer - Findings from Wuhan University advance knowledge in cervical cancer

Dengue Fever - Research from P. Liu and co-authors reveals new findings on dengue fever

Enzyme Research - Findings from University of Michigan in enzyme research reported

Escherichia Coli - Research from University of Queensland provides new data on Escherichia coli

Escherichia Coli - Researchers from Iowa State University publish findings in Escherichia coli

Escherichia Coli - Studies from University of Arizona reveal new findings on Escherichia coli

HIV/AIDS - New HIV/AIDS data have been reported by L.R. Salkeld and co-authors

Legionnaire Disease - Research reports on legionnaire disease from Josai University provide new insights

Legionnaire Disease - Studies from INSERM update current data on legionnaire disease

Life Sciences - New life sciences study findings reported from King Khalid University

Life Sciences - Research from University of Bath in life sciences provides new insights

Thromboembolism - Research results from St. John's University update knowledge of thromboembolism

Vascular Endothelial Growth Factor - New findings reported from Wuhan University describe advances in vascular endothelial growth factor

West Nile Virus - Data from S.L. Aspinall et al provide new insights into acute bronchitis

West Nile Virus - New west nile virus study results from University of California, Medical Department described

West Nile Virus - Research from J.E. Soverow and co-researchers in the area of west nile virus published

West Nile Virus - Research from Louisiana State University, Medical Department in the area of west nile virus described

West Nile Virus - Researchers from University of Texas detail new studies and findings in the area of west nile virus

West Nile Virus - Study results from University of Wyoming provide new insights into west nile virus

Yersinia - Colorado State University publishes research in yersinia

Anthrax - Research from Centers for Disease Control and Prevention provide new insights into anthrax

Anthrax Vaccines - Studies from University of Michigan, Department of Internal Medicine describe new findings in anthrax vaccines

Escherichia Coli Therapy - Studies from Mississippi State University yield new data on Escherichia coli therapy

Legionnaire Disease - Data on legionnaire disease detailed by researchers at Environmental Protection Agency

Life Sciences - Studies by L. Rusa and co-authors describe new findings in life sciences

A.P. Pharma, Inc. - A.P. Pharma Announces FDA Acceptance of APF530 New Drug Application for Chemotherapy-Induced Nausea and Vomiting

Anthrax - Human Genome Sciences Announces New Order for Raxibacumab (ABthrax(TM)) from U.S. Government

Aradigm Corporation - Aradigm Receives FDA Clearance for Phase IIb Clinical Trial of Inhaled Liposomal Ciprofloxacin to Treat Bronchiectasis

Asthma - Schering-Plough Announces U.S. Filing of Mometasone Furoate/Formoterol Fumarate Combination for the Maintenance Treatment of Asthma

BioDelivery Sciences International, Inc. - BioDelivery Sciences Receives $27 Million Milestone Payment from Meda AB

Biomedicine - $10,000 ISSAC Award for Innovation Presented to MIT PhD

Brachytherapy - Varian Medical Systems Receives 510(k) Clearance for Fast and Accurate Acuros(TM) Radiotherapy Treatment Planning Capability

Bristol-Myers Squibb Company - ImClone Systems and Bristol-Myers Squibb Announce Revisions to ERBITUX® cetuximab U.S. Product Labeling for Metastatic Colorectal Cancer

Candela Corporation - Candela Receives Registration Approval to Market the Alex TriVantage Laser in Brazil

Carcinoid - Lexicon's Drug Candidate LX1032 for Carcinoid Syndrome Receives Orphan Drug Designation From EMEA

Cardiology - Poniard Pharmaceuticals Announces Positive Cardiac Safety Data From Picoplatin Phase 1 Trial Supporting NDA Filing

Cavit Sciences, Inc. - Cavit Sciences Closing in on Revenues with Launch of WellnessSuite™

Cavit Sciences, Inc. - Cavit Sciences' National Health Services Inks National Deal for WellnessSuite ™

Colon Cancer - Amgen Announces KRAS Safety Update to U.S. Prescribing Information for Vectibix(R) (Panitumumab)

Columbia Laboratories, Inc. - Columbia Laboratories and PharmaBio Agree to One Year Extension of Final Payment under STRIANT® Financing Agreement

Contact Lens - A Drug-Dispensing Contact Lens

Depression - Labopharm receives complete response letter from the U.S. FDA for novel antidepressant

Drug Safety - SafeTScribe Technologies' Low Cost Time and Temperature Sensing Ink Enhances Food and Drug Safety and Quality Assurance

Edelman Public Relations - Data show ATryn effectively prevents serious blood clots

Elekta - Elekta CMS Software Receives FDA 510(k) Clearance for Monaco VMAT Treatment Planning Solution

Embera NeuroTherapeutics, Inc. - Embera NeuroTherapeutics Announces Expansion of Management Team after Successful Completion of Pilot Study of Cocaine Addiction Treatment

Family Research Council - FRC: Ryan Bill Increases Abortion While Claiming to 'Reduce Need' for Abortion

Genentech, Inc. - Xeloda®-Oxaliplatin Combination XELOX Shown to Be More Effective Than Standard Chemotherapy Regimen in Adjuvant Colon Cancer

Genzyme Corp. - Genzyme Delivers Solid Second-Quarter Financial Results

Golden Helix, Inc. - Golden Helix Offers Assistance for Rosetta Syllego Users

HCD Research - Docs Say No to Pulling Drugs Containing Acetaminophen off the Market

HemCon Medical Technologies, Inc. - Next-Generation Hemostatic Dressing Available for Military Emergencies

Hepatitis C Virus - FDA Approves VITROS(R) Anti-HCV Assay for Use On VITROS 5600(R) Integrated and VITROS 3600(R) Immunodiagnostic Systems

HIV/AIDS - 96-Week Safety and Efficacy Findings Presented for INTELENCE(TM) (etravirine) As Part of HIV Combination Therapy

HIV/AIDS - Abbott HIV Test Demonstrates Earlier Disease Detection

HIV/AIDS Co-Infection - BD/PEPFAR Lab-Strengthening Initiative Marks Progress in Fight Against HIV/AIDS and TB in Sub-Saharan Africa

Hypertension - FDA Approves Tekturna HCT(R) as Initial Treatment in Patients Unlikely to Achieve Their Blood Pressure Goals With a Single Agent

Incyte Corporation - Incyte Reaches Agreement with FDA on a Special Protocol Assessment for INCB18424 in Myelofibrosis

Jewish Hospital - World's First Cardiac Adult Stem Cell Patient Receives Infusion

Keratoconus - SynergEyes, Inc. Launches New Hybrid Lens Design for Keratoconus Patients

Lung Cancer - Sirnaomics Receives SBIR Grant from NIH/NCI for Its Multi-Targeted Lung Cancer siRNA Therapeutics

Lupus - First Potential Lupus-Specific Treatment in Sight

Merck - ISENTRESS® raltegravir, from Merck, was as Effective as Efavirenz at Suppressing HIV Viral Load and Increasing CD4 Cell Counts in Treatment-Naive Patients up to 144 Weeks When Used in Combination Therapy

Multiple Sclerosis - Merck Serono Submits Application for Cladribine Tablets as Multiple Sclerosis Therapy in Europe

Namic - CNN's Dr. Sanjay Gupta to Receive Mickey Leland Humanitarian Achievement Award at 23rd Annual NAMIC Conference

National Dental Pulp Laboratory, Inc. - National Dental Pulp Laboratory Offers Facts about the Promise of Dental Pulp

Non-Melanoma Skin Cancer - First Skin Cancer Patients Treated With Electronic Brachytherapy (eBx) At University of Wisconsin Riverview Cancer Center

Oncology - Comprehensive VMAT Solution From Elekta on Center Stage at 2009 AAPM Annual Meeting

Osteoporosis - FDA Approves Expanded Use of Lilly's FORTEO(R) [teriparatide (rDNA origin) injection] to Treat Glucocorticoid-Induced Osteoporosis

Perfusion - Masimo Receives FDA Clearance for New Rainbow(R) Resposable(TM) Sensor System

Pharmaceuticals - QRxPharma Initiates Comparative Phase 2 Proof-of-Concept Study for MoxDuo(TM) IV Pain Therapy

Pharmalucence, Inc. - Pharmalucence, Inc. Announces FDA Approval for its Generic Sestamibi Kit

Recall InfoLink - Recall InfoLink Announces Comprensive Offering for Product Tracking and Reporting and Consumer Safety

Regeneron Pharmaceuticals, Inc. - Regeneron Receives European Medicines Agency Positive Opinion for Marketing Authorization of Rilonacept for the Treatment of Cryopyrin-Associated Periodic Syndromes CAPS

Regulatory Actions - NeurogesX Announces Preliminary Results of FDA-Requested Qutenza(TM) Study

Regulatory Actions - Neusoft Medical's Latest Innovation, NeuViz 16 CT Scanner, Approved by FDA for the U.S. Market

Renaissance Life & Health Insurance Company of America - Renaissance Grants $3,000 to the Florida Dental Association to Present Oral Health Workshops for the Vulnerable Elderly

Research and Markets - New Innovations in in-Vitro Diagnostics Report - New Technologies, Growth Opportunities, and the Future Market Outlook

Safe Harbor - Safe Harbor(R) Helps Hollywood Say Bye-Bye to Mercury Fears in Fish

Seattle Genetics, Inc. - Seattle Genetics Initiates Brentuximab Vedotin SGN-35 Retreatment Clinical Trial

Signostics Inc. - Signostics Closes Follow-On Financing of US$4 Million, Expands Board of Directors

SpineAlign Medical, Inc. - SpineAlign Medical Treats First Patient in U.S. with New, Innovative System for Vertebral Compression Fracture Repair

Stem Cell Research - World's First Cardiac Adult Stem Cell Patient and Physicians Discuss Clinical Trial

Surgery - Accent on Aesthetics Plastic Surgery Medical Center Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler

Terumo Cardiovascular Systems - Terumo Cardiovascular Systems Initiates U.S. Clinical Trial for Anaconda AAA Stent Graft System

The Dow Chemical Company - Dow AgroSciences, Monsanto Complete U.S. and Canadian Regulatory Authorizations for SmartStax Corn; Plans Set to Launch Seed Platform on 3 Million- to 4 Million-Plus Acres

Therapy - Swissmedic Grants Debiopharm Marketing Authorisation for Moapar(R), a New Therapeutic Avenue for the Treatment of Sexual Deviations

Transcat, Inc. - Transcat, Inc. Partners with FLIR in the Test & Measurement Market

Turner Construction Company - Turner Selected by Centers for Disease Control and Prevention to Manage Construction of 311,000 Sq. Ft. Office Facility Adjacent to CDC Headquarters in Atlanta, GA

Universal Detection Technology - Universal Detection Technology Bio-Detection Kits Gain Momentum in Commercial Sector

University of Leicester - Stuff of stink bombs investigated for role in pregnancy



Return to Top of Page

-----------------------
PR Login